BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19779271)

  • 1. Role of purkinje fibers in the maintenance of ventricular fibrillation.
    Murakawa Y
    Circ J; 2009 Oct; 73(10):1793-4. PubMed ID: 19779271
    [No Abstract]   [Full Text] [Related]  

  • 2. Repetitive endocardial focal discharges during ventricular fibrillation with prolonged global ischemia in isolated rabbit hearts.
    Wu TJ; Lin SF; Hsieh YC; Chiu YT; Ting CT
    Circ J; 2009 Oct; 73(10):1803-11. PubMed ID: 19652397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of Purkinje activation in long duration ventricular fibrillation.
    Huang J; Dosdall DJ; Cheng KA; Li L; Rogers JM; Ideker RE
    J Am Heart Assoc; 2014 Feb; 3(1):e000495. PubMed ID: 24584738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical ablation of the Purkinje system causes early termination and activation rate slowing of long-duration ventricular fibrillation in dogs.
    Dosdall DJ; Tabereaux PB; Kim JJ; Walcott GP; Rogers JM; Killingsworth CR; Huang J; Robertson PG; Smith WM; Ideker RE
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H883-9. PubMed ID: 18586887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular fibrillation: how do we put the genie back in the bottle?
    Ideker RE
    Heart Rhythm; 2007 May; 4(5):665-74. PubMed ID: 17467640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocardial focal activation originating from Purkinje fibers plays a role in the maintenance of long duration ventricular fibrillation.
    Lin C; Jin Q; Zhang N; Zhou J; Pang Y; Xin Y; Liu S; Wu Q; Wu L
    Croat Med J; 2014 Apr; 55(2):121-7. PubMed ID: 24778098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of global ischemia and reperfusion during ventricular fibrillation in myopathic human hearts.
    Massé S; Farid T; Dorian P; Umapathy K; Nair K; Asta J; Ross H; Rao V; Sevaptsidis E; Nanthakumar K
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1984-91. PubMed ID: 19820201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T wave changes following right ventricular pacing.
    Harumi K; Mashima S; Tsutsumi T; Nirei T; Suwa J; Okazaki O; Wei D; Okamoto Y
    J Electrocardiol; 1995; 28 Suppl():142-7. PubMed ID: 8656102
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ventricular fibrillation and electric defibrillation].
    Rossi R
    Dtsch Med Wochenschr; 1989 Jan; 114(4):145-9. PubMed ID: 2644115
    [No Abstract]   [Full Text] [Related]  

  • 10. Pretreatment of BAPTA-AM suppresses the genesis of repetitive endocardial focal discharges and pacing-induced ventricular arrhythmia during global ischemia.
    Wu TJ; Lin SF; Hsieh YC; Lin TC; Lin JC; Ting CT
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1154-62. PubMed ID: 21489030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of chemical ablation of the endocardium on ventricular fibrillation threshold.
    Damiano RJ; Smith PK; Tripp HF; Asano T; Small KW; Lowe JE; Ideker RE; Cox JL
    Circulation; 1986 Sep; 74(3):645-52. PubMed ID: 3742762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection by preconditioning and cardiac pacing against ventricular arrhythmias resulting from ischemia and reperfusion.
    Parratt JR; Vegh A; Kaszala K; Papp JG
    Ann N Y Acad Sci; 1996 Sep; 793():98-107. PubMed ID: 8906159
    [No Abstract]   [Full Text] [Related]  

  • 13. A system for in-vivo cardiac optical mapping.
    Dillon SM; Kerner TE; Hoffman J; Menz V; Li KS; Michele JJ
    IEEE Eng Med Biol Mag; 1998; 17(1):95-108. PubMed ID: 9460625
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of chemical subendocardial ablation on activation rate gradient during ventricular fibrillation.
    Cha YM; Uchida T; Wolf PL; Peters BB; Fishbein MC; Karagueuzian HS; Chen PS
    Am J Physiol; 1995 Dec; 269(6 Pt 2):H1998-2009. PubMed ID: 8594909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Onset Recurrent Syncope Triggered by Fever.
    Arias MA; Pachón M; Loughlin G
    Circulation; 2020 Mar; 141(11):931-933. PubMed ID: 32176543
    [No Abstract]   [Full Text] [Related]  

  • 16. Site of the arrhythmogenic focus and cardiac vulnerability to ventricular fibrillation.
    Murakawa Y; Yamashita T; Ajiki K; Hayami N; Fukui E; Kasaoka Y; Omata M; Nagai R
    Pacing Clin Electrophysiol; 2002 Apr; 25(4 Pt 1):446-56. PubMed ID: 11991370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of arrhythmias and heart fibrillation in myocardial ischemia and the possible role of Purkinje cells in their origin].
    Beskrovnova NN; Sharov VG
    Arkh Patol; 1992; 54(6):42-5. PubMed ID: 1471932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological mechanisms involved in ventricular fibrillation.
    Zipes DP
    Circulation; 1975 Dec; 52(6 Suppl):III120-30. PubMed ID: 1182966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular fibrillation and defibrillation--what are the major unresolved issues?
    Ideker RE; Walcott GP; Epstein AE; Plumb VJ; Kay N
    Heart Rhythm; 2005 May; 2(5):555-8. PubMed ID: 15840486
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of Purkinje fibers in triggering polymorphic ventricular tachycardia and fibrillation in patient with myocardial infarction].
    Szumowski Z; Walczak F; Kepski R; Stepińska J; Banaszewski M; Przybylski A; Szwed H
    Kardiol Pol; 2003 Feb; 58(2):157-61. PubMed ID: 14504647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.